Demo Sign up Log In

Akebia Therapeutics Inc (AKBA)

Cash Conversion Ratio

-0.27×

Quarterly · Period ending: Jun 30, 2026

AKBA Cash Conversion Ratio

Latest reported-0.27×period endingJun 30, 2026

Latest reported-0.27×period endingJun 30, 2026

AKBA Quarterly Cash Conversion Ratio (-2.53× → -0.27×)

Latest values, visible window

High-resolution chart · PNG

AKBA cash conversion ratio history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Akebia Therapeutics Inc Cash Conversion Ratio — Quarterly
Period ending	Cash Conversion Ratio
Jun 30, 2026	-0.2746×
Mar 31, 2026	2.3423×
Dec 31, 2025	-2.5292×
Sep 30, 2025	51.9037×
Jun 30, 2025	89.9555×
Mar 31, 2025	-2.2259×
Dec 31, 2024	0.1959×
Sep 30, 2024	0.3342×
Jun 30, 2024	1.1763×
Mar 31, 2024	1.0805×
Dec 31, 2023	-3.759×
Sep 30, 2023	0.4947×
Jun 30, 2023	-0.3248×
Mar 31, 2023	0.6526×
Dec 31, 2022	7.2403×
Sep 30, 2022	-0.6249×
Jun 30, 2022	-1.0411×
Mar 31, 2022	0.3482×
Dec 31, 2021	0.899×
Sep 30, 2021	0.945×
Jun 30, 2021	0.7604×
Mar 31, 2021	1.0176×
Dec 31, 2020	0.3575×
Sep 30, 2020	0.455×
Jun 30, 2020	-0.2115×
Mar 31, 2020	1.4748×
Dec 31, 2019	0.9775×
Sep 30, 2019	-0.155×
Jun 30, 2019	0.6936×
Mar 31, 2019	1.9312×
Dec 31, 2018	0.8434×
Sep 30, 2018	0.4902×
Jun 30, 2018	-0.259×
Mar 31, 2018	0.8808×
Dec 31, 2017	-1.3704×
Sep 30, 2017	2.3867×
Jun 30, 2017	-1.1254×
Mar 31, 2017	0.2235×
Dec 31, 2016	-2.5255×

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.